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Haplotype association studies were performed in 10
unrelated South African families and 1 German immigrant
family with familial adenomatous polyposis (FAP). Three
DNA probes, recognising five restriction fragment length
polymorphisms (RFLPs) around the gene locus for FAP on
chromosome 5q, were used. The RFLP analysis was
informative or partially informative in all the families
studied. Five haplotypes were found to segregate with the
disease locus. The predominant association of two of
these haplotypes with FAP in the South African families
suggests that two mutations may cause the disease in
about 70% of families in this population. Meiotic
recombination events were detected between the FAP
gene and probe M4 (D5S6), but not probes Pi227 (D5S37)
and C11 p11 (D5S71). Haplotype analysis allowed the pre-
clinical diagnosis of FAP in 5 subjects.
S Atr Med J 1995; 85: 269-271.
Familial adenomatous polyposis (FAP) is an autosomal
dominant genetic disease. In their teens patients
characteristically develop many adenomatous polyps in the
large bowel. Symptoms of bleeding and diarrhoea usually
appear about 10 years later when patients are in their 30s.
Virtually 100% of untreated sufferers develop carcinoma of
the large bowel; this can be prevented in almost all cases by
removal of the colon before cancer develops. The absence
of rectal polyps at middle age does not mean that the
disease is absent, as occasionally polyps only appear later.
Potentially affected relatives of patients require regular
endoscopic examination of the rectum in order to screen for
the disease. As these examinations are unpleasant, patients
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are often understandably reluctant to undergo regular
examinations that must be continued for several decades.
With the recent identification'·2 and characterisation3,4 of the
gene which causes FAP, it was hoped that it would be
possible to screen potentially affected individuals for a
nearby informative marker sequence and, eventually, the
responsible mutation. This would allow a pre-clinical
diagnosis to be made early with a single blood test, and
obviate the need for repeated endoscopic examinations.
Polymorphic DNA probes which are closely linked to the
FAP gene have been used to trace the defective gene in
affected families.5.6 Lod scores of 7,85 and 3,26 at
recombination fractions of 0,05 and 0,0 were reported in
linkage studies with FAP for probes Pi227 and C11 p11 ,
respectively.'·5 Both these probes have been successfully
used in pre-clinical diagnosis of FAP.'-· In this study we
assessed the value of these probes, as well as probe M4
(D5S6) originally developed by Us,lO in the pre-clinical
diagnosis of FAP in 11 affected families. A study of
haplotype associations with FAP in the families has shown a
predominant association of two haplotypes with the disease.
Material and methods
Patients and families
Blood samples were collected from 123 members of 10
South African families and one white German immigrant
family, Of the South African families, 9 were white and 1 was
of mixed ancestry. Histopathological proof of FAP was
present in several members of each family. None of the
family units studied was known to be related at the level of
first or second cousin. The subjects were designated as
affected or unaffected according to the findings of rigid or
flexible sigmoidoscopy, colonoscopy or COlectomy,
supported by histopathological examination of mucosal
specimens where necessary, Subjects with an
endoscopically normal rectum after the age of 45 were
empirically regarded as unaffected. This was thought
reasonable in view of the findings of Murday and Slack."
Blood was taken with the informed consent of the patient
and ethical approval of the appropriate institutions.
DNA preparation and haplotype
analysis
DNA was prepared from blood samples by a standard
method.'2 Aliquots of DNA (5 ~g) were digested with the
appropriate restriction enzymes, size-separated on agarose
gels, transferred to nitrocellulose or nylon membranes and
hybridised with radio-labelled probes according to the
methods of Southern." The probes were labelled in vitro by
oligonucleotide radiolabelling to a specific activity of 1a·
cpm/~g DNA. The three polymorphic DNA probes used were
the following: (I) M4 (D5S6), a 7,6 kb BamHI fragment in
L47.1 ;'0 (il) Pi227 (D5S37), a 0,9 kb Hindlll/EcoRI fragment in
PiAN7;" and (iiJ) C11 p11 (D5S71), a 3,6 kb EcoRI fragment
in pUC8.' The restriction fragment length polymorphisms
(RFLPs) that these probes recognise and the restriction
enzymes used are reported in Table I. FAP-associated
haplotypes for all subjects were deduced by segregation
analysis or by homozygosity for all the RFLPs.
-,------------
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Table I. Allele sizes recognised on Southern blot analysis at
five polymorphic loci near the FAP gene locus
Probe
M4
C11 p11
Pi227
Results
Polymorphism
Enzyme Allele
BamHI 1
2
3
Taql 1
2
Pstl 1
2
Bcll 1
2
3
Mbol 1
2
Size (kb)
11,0
9,6
7,6
4,4
3,9
4,3
3,0
8,6 + 1,2
3,0
1,8 + 1,2
0,55
0,45
were identified between FAP and Pi227 or between FAP and
C11 p11. For this reason, and since M4 did not distinguish a
specific FAP-associated haplotype, the additional
haplotypes identified in normal chromosomes by using this
marker are not given in Table 11.
The DNA analysis was informative in all the families studied,
although only partly informative in 1. Of the individuals
studied, 27 were normal spouses, 52 were affected and 44
were at risk for FAP. The DNA diagnosis was uninformative in
4 of the 44 individuals at risk, while in the remainder, affected
haplotypes were assigned to 13 and normal haplotypes to 27.
To establish how accurately identification of the disease-
associated haplotype predicted the inheritance of FAp, 7
individuals with this haplotype were examined clinically and·in
5 FAP was proven histopathologically. Two subjects, aged 73
and 34 years respectively, were also shown to carry the
haplotype, although no signs of FAP could be detected.
An example of how DNA analysis was used to predict FAP in
an affected family is shown in Fig. 1. ;
Fig. 1. The segregation of proven FAP (shaded squares and
circles) and RFLPs of the disease gene in a family. The affected
haplotype is boxed. In individuals 111-2, 111-4 and 111-5 the finding
of the FAP haplotype suggested the presence of FAP before
clinical examination. In individual 111-2 FAP was subsequently
diagnosed by means of a colonoscopy. Individuals 111-4 and 111-5
have not yet been examined clinically.
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The aim of this study was to assess how accurately one was
able to diagnose FAP in members of affected South African
families, using DNA probes that identify RFLPs close to the
FAP gene. The potential clinical value of using linked DNA
probes to analyse an individual's risk of having FAP has
been examined by several groupS.79 Probes Pi227 and
C11 p11 are closely linked to the FAP gene and have been
successfully used in pre-c1inical diagnosis.',5 Our data,
obtained from 123 individuals in 11 families unrelated to the
second degree, provided further evidence that probes Pi227
and C11 p11 are potentially useful tools for the identification
of affected family members without clinical signs of FAP. The
haplotype analysis assigned high risk to 13 subjects. Of the
Table 11. Haplotypes of the FAP gene observed with probes
C11 p11 and Pi227 in the study population
We used five RFLPs to trace the inheritance of the FAP gene
in the 11 unrelated families. The three probes and restriction
enzymes used to recognise the RFLPs on chromosome 5q
are summarised in Table I. All variants showed autosomal
codominant inheritance in the families and five haplotypes
associated with FAP could be identified. Two of these
haplotypes were predominantly associated with the disease,
while three were identified in single families. The different
haplotypes identified in the families studied are shown in
Table 11. The haplotypic arrangement 2212 was associated
with the FAP mutation in the German immigrant family, while
haplotype 2232 showed disease association in 5 South
African families, including the one of mixed ancestry. The
frequencies of haplotypes for 49 normal chromosomes were
deduced from the patients and their unrelated spouses. In
addition to the five FAP-associated haplotypes another
seven were found in the normal population. Although a small
number of unrelated FAP cases were haplotyped, it is clear
that both the frequency and distribution of haplotypes differ
significantly between the normal and FAP samples. Analyses
of 77 phase-known meioses have shown that probe M4 was
involved in 5 recombination events, while no crossovers
No. of haplotypes
Probe/restriction enzyme FAP- Non-FAP
C11 p11 Pi227 associated associated'
Taql Pstl Bcll Mbol (N =11) (N =49)
2 2# 2 1 1 19 (38%)
2 2 3 2 5· 14 (29%)
2 2# 1 2 1 5 (10%)
2 1 3 2 3 3 (6%)
1 2 1 2 0 2 (4%)
1 2 3 2 0 1 (2%)
1 2 3 1 0 1 (2%)
2 2 3 1 0 1 (2%)
2 2 2 2 0 1 (2%)
2 1 2 1 0 1 (2%)
1 2 2 1 0 1 (2%)
1 1 3 2 1 0
* Haplotype frequencies in normal chromosomes are given in brackets.
# Unambiguous assignment of Psll RFLP alleles to specific haplotypes was not
possible in some of the individuals tested.
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7 subjects who were subsequently examined clinically, 5
were shown to be affected. Endoscopic examination of the
two remaining individuals showed them to be unaffected.
The 'affected' haplotypes might be present in them because
of recombination events, incomplete penetrance or because
the subjects have yet to develop polyps. These different
possibilities are discussed by Mareni and coworkers,9 who
describe a similar discrepancy between clinical phenotype
and DNA characteristics. The degree of usefulness of
different probes used in pre-c1inical diagnosis, as well as the
disease-associated chromosomal arrangements identified,
differ between populations.'·15 In the Dutch population, less
heterozygosity was detected by C11 p11 than in the English
population' As would be expected, the degree of
heterozygosity found in our population is closer to that of
the Dutch population.
We did not identify any crossovers between the FAP gene
and either probes Pi227 or C11 p11, but our probe M4 was
involved in 5 recombination events (77 meioses analysed).
In a study by Meera Khan and collaborators" in 1987, the
genetic distance between the FAP locus and M4 was
estimated to be about 25 cM. Because of low
informativeness, the data obtained from two additional 5q
probes developed during this study are not reported here.'·
Using four RFLPs identified by Pi227 and C11 p11, we
have determined the haplotypic arrangements of both
normal and FAP associated alleles in 119 of the 123 family
members. A total of eleven different haplotypes were
identified in 49 normal chromosomes. Four of these, as well
as one additional haplotype, were found to segregate
consistently with FAP in the 11 families studied. The
association of predominantly two haplotypes with FAP in the
South African families further indicated that two different
gene mutations may cause the disease in about 70% of
families in this population. This suggests the presence of
specific founder genes for FAP in some of the affected
families studied. This phenomenon has also been shown for
other genetic diseases in isolated populations. 17 '8 We have
previously confirmed the proposed 'founder effect' for
familial hypercholesterolaemia in South African Afrikaners'9
by haplotype studies20 and subsequent mutation detection!'
The recent identification of the FAP gene enables the
d~tection of disease-related mutations and should
eventually enable the development of rapid DNA-based
methods for diagnosis. The specific FAP-associated
\i-)aplotypes found to segregate in the families analysed by us
will facilitate the detection of mutations. This analysis
provided an indication of the number of different mutations
present in South African patients and confirmed that the
FAP ph,enotype segregating in the families is caused by
defects in the gene analysed. Although our results suggest
that four different mutations may cause FAP in the South
African families studied, there is the possibility that only one
mutation exists and has become associated with different
RFLP haplotypes by recombination events. It is, however,
more likely that the prediction of five mutations (including
OnE, in the German immigrant family) is a minimum estimate,
since the haplotypes may be genetically heterogeneous,
Wittl several mutations causing FAP present on the same
chromosomal background. Studies are currently in progress
to identify the gene mutations underlying FAP in the South
African population, which may confirm or refute the founder
hypothesis.
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Our results have shown that closely-linked polymorphic
DNA markers can be used to diagnose FAP in local families
before clinical proof is available. The problem of crossing
over between markers and the FAP gene can in future be
circumvented by the use of additional markers on either side
of the gene, thereby making the predictions totally reliable.'
Recently identified polymorphisms closer to and within the
FAP gene2223 are currently being investigated for this
purpose. Ultimately, the identification of the specific
mutations that cause the disease may enable us to predict
or exclude FAP reliably with a single test.
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